GuangYuYuan Chinese Herbal Medicine Co Ltd
GuangYuYuan Chinese Herbal Medicine Co., Ltd. manufactures and sells Chinese medicinal products. The company offers traditional Chinese medicine, fine Chinese medicine, and health wine. It provides its products in the form of pills, powders, tablets, hard capsules, granules, mixtures, and wine preparations. The company was formerly known as Topsun Science And Technology Co Ltd. and changed its na… Read more
GuangYuYuan Chinese Herbal Medicine Co Ltd (600771) - Net Assets
Latest net assets as of September 2025: CN¥1.67 Billion CNY
Based on the latest financial reports, GuangYuYuan Chinese Herbal Medicine Co Ltd (600771) has net assets worth CN¥1.67 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.46 Billion) and total liabilities (CN¥788.84 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.67 Billion |
| % of Total Assets | 67.94% |
| Annual Growth Rate | 24.04% |
| 5-Year Change | -35.59% |
| 10-Year Change | 115.8% |
| Growth Volatility | 178.66 |
GuangYuYuan Chinese Herbal Medicine Co Ltd - Net Assets Trend (1993–2024)
This chart illustrates how GuangYuYuan Chinese Herbal Medicine Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for GuangYuYuan Chinese Herbal Medicine Co Ltd (1993–2024)
The table below shows the annual net assets of GuangYuYuan Chinese Herbal Medicine Co Ltd from 1993 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.59 Billion | +5.49% |
| 2023-12-31 | CN¥1.51 Billion | -12.54% |
| 2022-12-31 | CN¥1.72 Billion | -19.47% |
| 2021-12-31 | CN¥2.14 Billion | -13.31% |
| 2020-12-31 | CN¥2.47 Billion | +1.14% |
| 2019-12-31 | CN¥2.44 Billion | +3.63% |
| 2018-12-31 | CN¥2.36 Billion | +18.99% |
| 2017-12-31 | CN¥1.98 Billion | +14.51% |
| 2016-12-31 | CN¥1.73 Billion | +134.59% |
| 2015-12-31 | CN¥737.13 Million | +760.64% |
| 2014-12-31 | CN¥85.65 Million | +16.28% |
| 2013-12-31 | CN¥73.65 Million | +43.04% |
| 2012-12-31 | CN¥51.49 Million | +107.85% |
| 2011-12-31 | CN¥-656.24 Million | +21.60% |
| 2010-12-31 | CN¥-836.99 Million | +18.51% |
| 2009-12-31 | CN¥-1.03 Billion | -23.60% |
| 2008-12-31 | CN¥-831.01 Million | +13.71% |
| 2007-12-31 | CN¥-963.09 Million | -262.92% |
| 2006-12-31 | CN¥591.15 Million | +12.75% |
| 2005-12-31 | CN¥524.31 Million | +9.36% |
| 2004-12-31 | CN¥479.43 Million | +10.03% |
| 2003-12-31 | CN¥435.74 Million | +6.03% |
| 2002-12-31 | CN¥410.96 Million | +9.68% |
| 2001-12-31 | CN¥374.69 Million | +30.98% |
| 2000-12-31 | CN¥286.07 Million | +19.40% |
| 1999-12-31 | CN¥239.60 Million | +71.89% |
| 1998-12-31 | CN¥139.39 Million | +8.85% |
| 1997-12-31 | CN¥128.06 Million | +11.13% |
| 1996-12-31 | CN¥115.24 Million | +287.85% |
| 1995-12-31 | CN¥29.71 Million | +382.42% |
| 1994-12-31 | CN¥6.16 Million | +208.10% |
| 1993-12-31 | CN¥2.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to GuangYuYuan Chinese Herbal Medicine Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 119534.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CN¥489.49 Million | 31.18% |
| Other Comprehensive Income | CN¥484.52 Million | 30.86% |
| Other Components | CN¥1.13 Billion | 71.98% |
| Total Equity | CN¥1.57 Billion | 100.00% |
GuangYuYuan Chinese Herbal Medicine Co Ltd Competitors by Market Cap
The table below lists competitors of GuangYuYuan Chinese Herbal Medicine Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BIOGAIA AB B O.N.
F:BGLA
|
$760.05 Million |
|
Bank of Xi'An Co Ltd
SHG:600928
|
$760.37 Million |
|
Garden Reach Shipbuilders & Engineers Limited
NSE:GRSE
|
$760.61 Million |
|
PT Bumi Resources Tbk
PINK:PBMRF
|
$760.82 Million |
|
Elang Mahkota Teknologi Tbk
JK:EMTK
|
$759.76 Million |
|
Shandong Kaisheng New Materials Co.Ltd.
SHE:301069
|
$759.65 Million |
|
HJ ShipBuilding & Construction Co Ltd
KO:097230
|
$759.55 Million |
|
Jiangsu Zhengdan Chemical Industry Co Ltd
SHE:300641
|
$759.51 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in GuangYuYuan Chinese Herbal Medicine Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,496,127,641 to 1,569,808,332, a change of 73,680,691 (4.9%).
- Net income of 74,453,023 contributed positively to equity growth.
- Dividend payments of 3,949,561 reduced retained earnings.
- Other comprehensive income increased equity by 487,038,136.
- Other factors decreased equity by 483,860,907.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥74.45 Million | +4.74% |
| Dividends Paid | CN¥3.95 Million | -0.25% |
| Other Comprehensive Income | CN¥487.04 Million | +31.03% |
| Other Changes | CN¥-483.86 Million | -30.82% |
| Total Change | CN¥- | 4.92% |
Book Value vs Market Value Analysis
This analysis compares GuangYuYuan Chinese Herbal Medicine Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.37x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 2261.93x to 5.37x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1993-12-31 | CN¥0.01 | CN¥16.99 | x |
| 1994-12-31 | CN¥0.02 | CN¥16.99 | x |
| 1995-12-31 | CN¥0.11 | CN¥16.99 | x |
| 1996-12-31 | CN¥0.43 | CN¥16.99 | x |
| 1997-12-31 | CN¥0.48 | CN¥16.99 | x |
| 1998-12-31 | CN¥0.52 | CN¥16.99 | x |
| 1999-12-31 | CN¥0.90 | CN¥16.99 | x |
| 2000-12-31 | CN¥1.10 | CN¥16.99 | x |
| 2001-12-31 | CN¥1.25 | CN¥16.99 | x |
| 2002-12-31 | CN¥1.36 | CN¥16.99 | x |
| 2003-12-31 | CN¥1.51 | CN¥16.99 | x |
| 2004-12-31 | CN¥1.52 | CN¥16.99 | x |
| 2005-12-31 | CN¥1.65 | CN¥16.99 | x |
| 2006-12-31 | CN¥1.71 | CN¥16.99 | x |
| 2007-12-31 | CN¥-3.26 | CN¥16.99 | x |
| 2008-12-31 | CN¥-2.77 | CN¥16.99 | x |
| 2009-12-31 | CN¥-3.34 | CN¥16.99 | x |
| 2010-12-31 | CN¥-2.74 | CN¥16.99 | x |
| 2011-12-31 | CN¥-1.97 | CN¥16.99 | x |
| 2012-12-31 | CN¥0.06 | CN¥16.99 | x |
| 2013-12-31 | CN¥0.14 | CN¥16.99 | x |
| 2014-12-31 | CN¥0.25 | CN¥16.99 | x |
| 2015-12-31 | CN¥2.52 | CN¥16.99 | x |
| 2016-12-31 | CN¥4.37 | CN¥16.99 | x |
| 2017-12-31 | CN¥3.87 | CN¥16.99 | x |
| 2018-12-31 | CN¥6.48 | CN¥16.99 | x |
| 2019-12-31 | CN¥4.82 | CN¥16.99 | x |
| 2020-12-31 | CN¥4.93 | CN¥16.99 | x |
| 2021-12-31 | CN¥4.29 | CN¥16.99 | x |
| 2022-12-31 | CN¥3.48 | CN¥16.99 | x |
| 2023-12-31 | CN¥2.99 | CN¥16.99 | x |
| 2024-12-31 | CN¥3.16 | CN¥16.99 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently GuangYuYuan Chinese Herbal Medicine Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.74%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.10%
- • Asset Turnover: 0.54x
- • Equity Multiplier: 1.45x
- Recent ROE (4.74%) is below the historical average (63.52%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1993 | 136.57% | 14.24% | 0.71x | 13.43x | CN¥2.53 Million |
| 1994 | 47.97% | 9.91% | 0.61x | 7.87x | CN¥2.34 Million |
| 1995 | 35.85% | 14.72% | 0.76x | 3.19x | CN¥7.68 Million |
| 1996 | 10.36% | 14.37% | 0.43x | 1.66x | CN¥420.22K |
| 1997 | 10.01% | 10.53% | 0.43x | 2.22x | CN¥18.50K |
| 1998 | 8.13% | 8.69% | 0.44x | 2.13x | CN¥-2.61 Million |
| 1999 | 11.97% | 12.07% | 0.64x | 1.54x | CN¥4.72 Million |
| 2000 | 18.19% | 17.09% | 0.47x | 2.26x | CN¥23.93 Million |
| 2001 | 13.43% | 10.04% | 0.44x | 3.02x | CN¥11.43 Million |
| 2002 | 10.26% | 7.38% | 0.43x | 3.26x | CN¥939.49K |
| 2003 | 7.08% | 5.08% | 0.26x | 5.38x | CN¥-11.72 Million |
| 2004 | 7.45% | 5.34% | 0.26x | 5.45x | CN¥-10.31 Million |
| 2005 | 8.02% | 6.43% | 0.23x | 5.42x | CN¥-8.73 Million |
| 2006 | 4.60% | 3.34% | 0.24x | 5.68x | CN¥-24.54 Million |
| 2007 | 0.00% | -144.64% | 0.31x | 0.00x | CN¥-657.00 Million |
| 2008 | 0.00% | 93.25% | 0.23x | 0.00x | CN¥381.10 Million |
| 2009 | 0.00% | -58.01% | 0.22x | 0.00x | CN¥-34.45 Million |
| 2010 | 0.00% | 84.75% | 0.19x | 0.00x | CN¥287.65 Million |
| 2011 | 0.00% | 132.30% | 0.28x | 0.00x | CN¥367.20 Million |
| 2012 | 1676.45% | 136.42% | 0.36x | 34.00x | CN¥353.45 Million |
| 2013 | -41.22% | -7.30% | 0.51x | 11.09x | CN¥-24.31 Million |
| 2014 | 43.57% | 10.35% | 0.77x | 5.50x | CN¥28.24 Million |
| 2015 | 0.28% | 0.47% | 0.40x | 1.49x | CN¥-69.47 Million |
| 2016 | 7.19% | 13.11% | 0.44x | 1.25x | CN¥-48.01 Million |
| 2017 | 12.37% | 20.26% | 0.46x | 1.32x | CN¥45.42 Million |
| 2018 | 16.35% | 23.11% | 0.53x | 1.35x | CN¥145.35 Million |
| 2019 | 5.52% | 10.69% | 0.34x | 1.50x | CN¥-105.63 Million |
| 2020 | 1.33% | 2.88% | 0.29x | 1.57x | CN¥-209.21 Million |
| 2021 | -15.06% | -37.02% | 0.28x | 1.48x | CN¥-526.19 Million |
| 2022 | -14.69% | -22.11% | 0.42x | 1.60x | CN¥-420.19 Million |
| 2023 | 6.02% | 7.02% | 0.49x | 1.76x | CN¥-59.53 Million |
| 2024 | 4.74% | 6.10% | 0.54x | 1.45x | CN¥-82.53 Million |
Industry Comparison
This section compares GuangYuYuan Chinese Herbal Medicine Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - General industry.
Industry Context
- Industry: Drug Manufacturers - General
- Average net assets among peers: $793,872,624
- Average return on equity (ROE) among peers: 7.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| GuangYuYuan Chinese Herbal Medicine Co Ltd (600771) | CN¥1.67 Billion | 136.57% | 0.47x | $759.87 Million |
| Zhejiang Int'L Group Co Ltd (000411) | $189.44 Million | 3.08% | 4.33x | $199.04 Million |
| Zhejiang Zhenyuan Share Co Ltd (000705) | $485.74 Million | 1.60% | 0.77x | $307.06 Million |
| Hunan Jingfeng Pharmaceutical (000908) | $336.40 Million | 0.81% | 1.44x | $202.85 Million |
| Hubei Guangji Pharmaceutical Co Ltd (000952) | $1.49 Billion | 3.37% | 0.66x | $229.65 Million |
| Zhejiang Haisen Pharmaceutical Co. Ltd. A (001367) | $1.25 Billion | 8.38% | 0.07x | $144.69 Million |
| Yifan Xinfu Pharmaceutical Co Ltd (002019) | $507.64 Million | 23.17% | 1.09x | $1.01 Billion |
| Guangdong Jiaying Pharmaceutical Co Ltd (002198) | $226.35 Million | 6.06% | 0.04x | $447.60 Million |
| Chongqing Lummy Pharmaceutical (300006) | $1.88 Billion | -4.66% | 0.52x | $475.43 Million |
| Zhejiang Jolly Pharmaceutical Co Ltd (300181) | $1.39 Billion | 1.50% | 0.52x | $1.19 Billion |
| Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) | $181.38 Million | 29.65% | 0.05x | $893.83 Million |